David Dechambre
Papers
4
Total Citations
77
H-Index
4
About
David Dechambre is a radiation oncologist whose research has made significant contributions to the field of stereotactic body radiotherapy (SBRT), with a particular focus on robotic radiosurgery systems, most notably the CyberKnife® platform. His work centers on the clinical application of SBRT for complex oncological scenarios, including oligorecurrent and metastatic disease affecting the lungs and liver — areas where surgical options are often limited or unavailable. Dechambre's most impactful studies have systematically evaluated treatment efficacy and toxicity profiles across diverse patient populations, offering clinicians valuable guidance on local control rates and the influence of tumor, patient, and treatment-related variables on outcomes. His 2017 report on 130 patients treated for primary and secondary lung tumors provided one of the more comprehensive clinical datasets in robotic SBRT, accumulating 19 citations, while his investigations into hepatic oligorecurrence and pulmonary metastases have further shaped protocols in this evolving subspecialty. Beyond clinical research, Dechambre has contributed to the technical foundation of robotic radiosurgery, authoring a cited commissioning study for Monte Carlo dose calculation algorithms. Collectively, his work — spanning physics, clinical outcomes, and emerging indications — has helped establish evidence-based frameworks for precision radiotherapy in challenging metastatic settings.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4